Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | STDN | NCNO |
|---|---|---|
| Price | $13.01 | $19.28 |
| Change today | ▲ 3.91% | ▲ 3.21% |
| Market cap | $2.04B | $2.04B |
| Return, 3 months | – | +6.8% |
| Return, year to date | – | -24.8% |
| Return, 1 year | – | -26.0% |
| P/E (TTM) | -121.6 | 62.2 |
| P/B | -26.2 | 2.2 |
| P/E percentile vs own 5y | 42nd | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +10.0% |
| Net profit growth (YoY) | – | +129.4% |
| Gross margin | -144.4% | 60.6% |
| Operating margin | -287.6% | 0.6% |
| Net margin | -494.9% | 1.6% |
| Return on equity | – | – |
| Analyst target vs. price | +28.1% | +28.0% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 53 | 45 |
| 30-day volatility | 93.8% | 51.4% |
| Max drawdown, 1 year | -40.4% | -52.2% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
